Report Overview
Peripheral drug-eluting balloons (DEBs) are medical devices used in the treatment of peripheral artery disease (PAD). These balloons are coated with an anti-proliferative drug that is released into the artery during angioplasty, helping to prevent restenosis by inhibiting the growth of scar tissue. Peripheral DEBs are designed to deliver targeted therapy to the site of the arterial lesion, offering a minimally invasive treatment option for patients with PAD. This technology represents a significant advancement in the field of interventional cardiology, providing an alternative to traditional balloon angioplasty and stenting procedures.
The market for peripheral drug-eluting balloons is experiencing steady growth driven by several key factors. One of the primary market drivers is the increasing prevalence of PAD globally, particularly among the aging population. As the incidence of risk factors such as diabetes, obesity, and smoking continues to rise, the demand for effective treatment options for PAD is also increasing. Peripheral DEBs offer a less invasive and more cost-effective alternative to traditional revascularization procedures, making them an attractive option for both patients and healthcare providers. Additionally, advancements in balloon coating technologies and the development of new drug formulations are further driving market growth by improving the efficacy and safety profile of these devices.
In addition to the growing prevalence of PAD and technological advancements, the market for peripheral drug-eluting balloons is also influenced by factors such as increasing healthcare expenditure, rising awareness about minimally invasive treatment options, and expanding reimbursement policies. These factors are expected to contribute to the continued expansion of the market in the coming years. However, challenges such as the high cost of DEB procedures, limited availability of specialized healthcare facilities, and regulatory hurdles in some regions may hinder market growth to some extent. Overall, the market for peripheral drug-eluting balloons is poised for significant growth as the demand for minimally invasive treatment options for PAD continues to rise.
The global Peripheral Drug-eluting Balloon market size was estimated at USD 609.80 million in 2024 and is projected to reach USD 1446.34 million by 2033, exhibiting a CAGR of 11.40% during the forecast period.
This report provides a deep insight into the global Peripheral Drug-eluting Balloon market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, PEST analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Peripheral Drug-eluting Balloon Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Peripheral Drug-eluting Balloon market in any manner.
Global Peripheral Drug-eluting Balloon Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Medtronic
Boston Scientific
Terumo Corporation
Acotec
BD
Surmodics
Biotronik
Shanghai MicroPort Endovascular MedTech(Group)Co.
Ltd.
Zylox-Tonbridge Medical Technology Co.
Ltd.
Market Segmentation (by Type)
Paclitaxel
Others
Market Segmentation (by Application)
Lower Limbs
Renal Artery
Carotid Artery
Geographic Segmentation
Table of Contents 1 Research Methodology and Statistical Scope 1.1 Market Definition and Statistical Scope of Peripheral Drug-eluting Balloon 1.2 Key Market Segments 1.2.1 Peripheral Drug-eluting Balloon Segment by Type 1.2.2 Peripheral Drug-eluting Balloon Segment by Application 1.3 Methodology & Sources of Information 1.3.1 Research Methodology 1.3.2 Research Process 1.3.3 Market Breakdown and Data Triangulation 1.3.4 Base Year 1.3.5 Report Assumptions & Caveats 2 Peripheral Drug-eluting Balloon Market Overview 2.1 Global Market Overview 2.1.1 Global Peripheral Drug-eluting Balloon Market Size (M USD) Estimates and Forecasts (2020-2033) 2.1.2 Global Peripheral Drug-eluting Balloon Sales Estimates and Forecasts (2020-2033) 2.2 Market Segment Executive Summary 2.3 Global Market Size by Region 3 Peripheral Drug-eluting Balloon Market Competitive Landscape 3.1 Company Assessment Quadrant 3.2 Global Peripheral Drug-eluting Balloon Product Life Cycle 3.3 Global Peripheral Drug-eluting Balloon Sales by Manufacturers (2020-2025) 3.4 Global Peripheral Drug-eluting Balloon Revenue Market Share by Manufacturers (2020-2025) 3.5 Peripheral Drug-eluting Balloon Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.6 Global Peripheral Drug-eluting Balloon Average Price by Manufacturers (2020-2025) 3.7 Manufacturers Peripheral Drug-eluting Balloon Sales Sites, Area Served, Product Type 3.8 Peripheral Drug-eluting Balloon Market Competitive Situation and Trends 3.8.1 Peripheral Drug-eluting Balloon Market Concentration Rate 3.8.2 Global 5 and 10 Largest Peripheral Drug-eluting Balloon Players Market Share by Revenue 3.8.3 Mergers & Acquisitions, Expansion 4 Peripheral Drug-eluting Balloon Industry Chain Analysis 4.1 Peripheral Drug-eluting Balloon Industry Chain Analysis 4.2 Market Overview of Key Raw Materials 4.3 Midstream Market Analysis 4.4 Downstream Customer Analysis 5 The Development and Dynamics of Peripheral Drug-eluting Balloon Market 5.1 Key Development Trends 5.2 Driving Factors 5.3 Market Challenges 5.4 Market Restraints 5.5 Industry News 5.5.1 New Product Developments 5.5.2 Mergers & Acquisitions 5.5.3 Expansions 5.5.4 Collaboration/Supply Contracts 5.6 PEST Analysis 5.6.1 Industry Policies Analysis 5.6.2 Economic Environment Analysis 5.6.3 Social Environment Analysis 5.6.4 Technological Environment Analysis 5.7 Global Peripheral Drug-eluting Balloon Market Porter's Five Forces Analysis 5.7.1 Global Trade Frictions 5.7.2 Global Trade Frictions and Their Impacts to Peripheral Drug-eluting Balloon Market 5.8 ESG Ratings of Leading Companies 6 Peripheral Drug-eluting Balloon Market Segmentation by Type 6.1 Evaluation Matrix of Segment Market Development Potential (Type) 6.2 Global Peripheral Drug-eluting Balloon Sales Market Share by Type (2020-2025) 6.3 Global Peripheral Drug-eluting Balloon Market Size Market Share by Type (2020-2025) 6.4 Global Peripheral Drug-eluting Balloon Price by Type (2020-2025) 7 Peripheral Drug-eluting Balloon Market Segmentation by Application 7.1 Evaluation Matrix of Segment Market Development Potential (Application) 7.2 Global Peripheral Drug-eluting Balloon Market Sales by Application (2020-2025) 7.3 Global Peripheral Drug-eluting Balloon Market Size (M USD) by Application (2020-2025) 7.4 Global Peripheral Drug-eluting Balloon Sales Growth Rate by Application (2020-2025) 8 Peripheral Drug-eluting Balloon Market Sales by Region 8.1 Global Peripheral Drug-eluting Balloon Sales by Region 8.1.1 Global Peripheral Drug-eluting Balloon Sales by Region 8.1.2 Global Peripheral Drug-eluting Balloon Sales Market Share by Region 8.2 Global Peripheral Drug-eluting Balloon Market Size by Region 8.2.1 Global Peripheral Drug-eluting Balloon Market Size by Region 8.2.2 Global Peripheral Drug-eluting Balloon Market Size Market Share by Region 8.3 North America 8.3.1 North America Peripheral Drug-eluting Balloon Sales by Country 8.3.2 North America Peripheral Drug-eluting Balloon Market Size by Country 8.3.3 U.S. Market Overview 8.3.4 Canada Market Overview 8.3.5 Mexico Market Overview 8.4 Europe 8.4.1 Europe Peripheral Drug-eluting Balloon Sales by Country 8.4.2 Europe Peripheral Drug-eluting Balloon Market Size by Country 8.4.3 Germany Market Overview 8.4.4 France Market Overview 8.4.5 U.K. Market Overview 8.4.6 Italy Market Overview 8.4.7 Spain Market Overview 8.5 Asia Pacific 8.5.1 Asia Pacific Peripheral Drug-eluting Balloon Sales by Region 8.5.2 Asia Pacific Peripheral Drug-eluting Balloon Market Size by Region 8.5.3 China Market Overview 8.5.4 Japan Market Overview 8.5.5 South Korea Market Overview 8.5.6 India Market Overview 8.5.7 Southeast Asia Market Overview 8.6 South America 8.6.1 South America Peripheral Drug-eluting Balloon Sales by Country 8.6.2 South America Peripheral Drug-eluting Balloon Market Size by Country 8.6.3 Brazil Market Overview 8.6.4 Argentina Market Overview 8.6.5 Columbia Market Overview 8.7 Middle East and Africa 8.7.1 Middle East and Africa Peripheral Drug-eluting Balloon Sales by Region 8.7.2 Middle East and Africa Peripheral Drug-eluting Balloon Market Size by Region 8.7.3 Saudi Arabia Market Overview 8.7.4 UAE Market Overview 8.7.5 Egypt Market Overview 8.7.6 Nigeria Market Overview 8.7.7 South Africa Market Overview 9 Peripheral Drug-eluting Balloon Market Production by Region 9.1 Global Production of Peripheral Drug-eluting Balloon by Region(2020-2025) 9.2 Global Peripheral Drug-eluting Balloon Revenue Market Share by Region (2020-2025) 9.3 Global Peripheral Drug-eluting Balloon Production, Revenue, Price and Gross Margin (2020-2025) 9.4 North America Peripheral Drug-eluting Balloon Production 9.4.1 North America Peripheral Drug-eluting Balloon Production Growth Rate (2020-2025) 9.4.2 North America Peripheral Drug-eluting Balloon Production, Revenue, Price and Gross Margin (2020-2025) 9.5 Europe Peripheral Drug-eluting Balloon Production 9.5.1 Europe Peripheral Drug-eluting Balloon Production Growth Rate (2020-2025) 9.5.2 Europe Peripheral Drug-eluting Balloon Production, Revenue, Price and Gross Margin (2020-2025) 9.6 Japan Peripheral Drug-eluting Balloon Production (2020-2025) 9.6.1 Japan Peripheral Drug-eluting Balloon Production Growth Rate (2020-2025) 9.6.2 Japan Peripheral Drug-eluting Balloon Production, Revenue, Price and Gross Margin (2020-2025) 9.7 China Peripheral Drug-eluting Balloon Production (2020-2025) 9.7.1 China Peripheral Drug-eluting Balloon Production Growth Rate (2020-2025) 9.7.2 China Peripheral Drug-eluting Balloon Production, Revenue, Price and Gross Margin (2020-2025) 10 Key Companies Profile 10.1 Medtronic 10.1.1 Medtronic Basic Information 10.1.2 Medtronic Peripheral Drug-eluting Balloon Product Overview 10.1.3 Medtronic Peripheral Drug-eluting Balloon Product Market Performance 10.1.4 Medtronic Business Overview 10.1.5 Medtronic SWOT Analysis 10.1.6 Medtronic Recent Developments 10.2 Boston Scientific 10.2.1 Boston Scientific Basic Information 10.2.2 Boston Scientific Peripheral Drug-eluting Balloon Product Overview 10.2.3 Boston Scientific Peripheral Drug-eluting Balloon Product Market Performance 10.2.4 Boston Scientific Business Overview 10.2.5 Boston Scientific SWOT Analysis 10.2.6 Boston Scientific Recent Developments 10.3 Terumo Corporation 10.3.1 Terumo Corporation Basic Information 10.3.2 Terumo Corporation Peripheral Drug-eluting Balloon Product Overview 10.3.3 Terumo Corporation Peripheral Drug-eluting Balloon Product Market Performance 10.3.4 Terumo Corporation Business Overview 10.3.5 Terumo Corporation SWOT Analysis 10.3.6 Terumo Corporation Recent Developments 10.4 Acotec 10.4.1 Acotec Basic Information 10.4.2 Acotec Peripheral Drug-eluting Balloon Product Overview 10.4.3 Acotec Peripheral Drug-eluting Balloon Product Market Performance 10.4.4 Acotec Business Overview 10.4.5 Acotec Recent Developments 10.5 BD 10.5.1 BD Basic Information 10.5.2 BD Peripheral Drug-eluting Balloon Product Overview 10.5.3 BD Peripheral Drug-eluting Balloon Product Market Performance 10.5.4 BD Business Overview 10.5.5 BD Recent Developments 10.6 Surmodics 10.6.1 Surmodics Basic Information 10.6.2 Surmodics Peripheral Drug-eluting Balloon Product Overview 10.6.3 Surmodics Peripheral Drug-eluting Balloon Product Market Performance 10.6.4 Surmodics Business Overview 10.6.5 Surmodics Recent Developments 10.7 Biotronik 10.7.1 Biotronik Basic Information 10.7.2 Biotronik Peripheral Drug-eluting Balloon Product Overview 10.7.3 Biotronik Peripheral Drug-eluting Balloon Product Market Performance 10.7.4 Biotronik Business Overview 10.7.5 Biotronik Recent Developments 10.8 Shanghai MicroPort Endovascular MedTech(Group)Co. 10.8.1 Shanghai MicroPort Endovascular MedTech(Group)Co. Basic Information 10.8.2 Shanghai MicroPort Endovascular MedTech(Group)Co. Peripheral Drug-eluting Balloon Product Overview 10.8.3 Shanghai MicroPort Endovascular MedTech(Group)Co. Peripheral Drug-eluting Balloon Product Market Performance 10.8.4 Shanghai MicroPort Endovascular MedTech(Group)Co. Business Overview 10.8.5 Shanghai MicroPort Endovascular MedTech(Group)Co. Recent Developments 10.9 Ltd. 10.9.1 Ltd. Basic Information 10.9.2 Ltd. Peripheral Drug-eluting Balloon Product Overview 10.9.3 Ltd. Peripheral Drug-eluting Balloon Product Market Performance 10.9.4 Ltd. Business Overview 10.9.5 Ltd. Recent Developments 10.10 Zylox-Tonbridge Medical Technology Co. 10.10.1 Zylox-Tonbridge Medical Technology Co. Basic Information 10.10.2 Zylox-Tonbridge Medical Technology Co. Peripheral Drug-eluting Balloon Product Overview 10.10.3 Zylox-Tonbridge Medical Technology Co. Peripheral Drug-eluting Balloon Product Market Performance 10.10.4 Zylox-Tonbridge Medical Technology Co. Business Overview 10.10.5 Zylox-Tonbridge Medical Technology Co. Recent Developments 10.11 Ltd. 10.11.1 Ltd. Basic Information 10.11.2 Ltd. Peripheral Drug-eluting Balloon Product Overview 10.11.3 Ltd. Peripheral Drug-eluting Balloon Product Market Performance 10.11.4 Ltd. Business Overview 10.11.5 Ltd. Recent Developments 11 Peripheral Drug-eluting Balloon Market Forecast by Region 11.1 Global Peripheral Drug-eluting Balloon Market Size Forecast 11.2 Global Peripheral Drug-eluting Balloon Market Forecast by Region 11.2.1 North America Market Size Forecast by Country 11.2.2 Europe Peripheral Drug-eluting Balloon Market Size Forecast by Country 11.2.3 Asia Pacific Peripheral Drug-eluting Balloon Market Size Forecast by Region 11.2.4 South America Peripheral Drug-eluting Balloon Market Size Forecast by Country 11.2.5 Middle East and Africa Forecasted Sales of Peripheral Drug-eluting Balloon by Country 12 Forecast Market by Type and by Application (2026-2033) 12.1 Global Peripheral Drug-eluting Balloon Market Forecast by Type (2026-2033) 12.1.1 Global Forecasted Sales of Peripheral Drug-eluting Balloon by Type (2026-2033) 12.1.2 Global Peripheral Drug-eluting Balloon Market Size Forecast by Type (2026-2033) 12.1.3 Global Forecasted Price of Peripheral Drug-eluting Balloon by Type (2026-2033) 12.2 Global Peripheral Drug-eluting Balloon Market Forecast by Application (2026-2033) 12.2.1 Global Peripheral Drug-eluting Balloon Sales (K Units) Forecast by Application 12.2.2 Global Peripheral Drug-eluting Balloon Market Size (M USD) Forecast by Application (2026-2033) 13 Conclusion and Key Findings
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook